References
- National Institute on Deafness and Other Communication Disorders (NIDCD). Quick statistics. Updated 2010 [Internet]. Available from: http://www.nidcd.nih.gov/health/statistics/Pages/quick.aspx
- Gantz BJ, Turner C, Gfeller KE, et al. Preservation of hearing in cochlear implant surgery: advantages of combined electrical and acoustical speech processing. Laryngoscope. 2005;115:796–802.
- Briggs RJ, Tykocinski M, Stidham K, et al. Cochleostomy site: implications for electrode placement and hearing preservation. Acta Otolaryngol. 2005;125:870–876.
- O'Leary MJ, Fayad J, House WF, et al. Electrode insertion trauma in cochlear implantation. Ann Otol Rhinol Laryngol. 1991;100:695–699.
- Seidman MD, Vivek P. Intratympanic treatment of hearing loss with novel and traditional agents. Otolaryngol Clin North Am. 2004;37:973–990.
- Eshraghi AA, Gupta C, Van D, Water TR, et al. Molecular mechanisms involved in cochlear implantation trauma and the protection of hearing and auditory sensory cells by inhibition of c-jun-N-terminal kinase signaling. Laryngoscope. 2013;123(Suppl 1):S1–S14.
- Van De Water TR, Dinh CT, Vivero R, et al. Mechanisms of hearing loss from trauma and inflammation: otoprotective therapies from the laboratory to the clinic. Acta Otolaryngol. 2010;130:308–311.
- Imam L, Hannan SA. Noise-induced hearing loss: a modern epidemic?. Br J Hosp Med (Lond). 2017;78:286–290.
- Wu Q, Wang GP, Xie J, et al. Tumor necrosis factor-α-induced ototoxicity in mouse cochlear organotypic culture. PLoS One. 2015;10:e0127703.
- Furness DN. Molecular basis of hair cell loss. Cell Tissue Res. 2015;361:387–399.
- Kopke RD, Jackson RL, Coleman JK, et al. NAC for noise: from the bench top to the clinic. Hear Res. 2007;226:114–125.
- Eshraghi AA, Roell J, Shaikh N, et al. A novel combination of drug therapy to protect residual hearing post cochlear implant surgery. Acta Otolaryngol. 2016;136:420–424.
- Eshraghi AA, Hoosien G, Ramsay S, et al. Inhibition of the JNK signal cascade conserves hearing against electrode insertion trauma-induced loss. Cochlear Implants Int. 2010;11(Suppl 1):104–109.
- Eshraghi AA, Lang DM, Roell J, et al. Mechanisms of programmed cell death signaling in hair cells and support cells post-electrode insertion trauma. Acta Otolaryngol. 2015;135:328–334.
- Lindblad AC, Rosenhall U, Olofsson A, et al. The efficacy of N-acetylcysteine to protect the human cochlea from subclinical hearing loss caused by impulse noise: a controlled trial. Noise Health. 2011;13:392–401.
- Riga MG, Chelis L, Kakolyris S, et al. Transtympanic injections of N-acetylcysteine for the prevention of cisplatin-induced ototoxicity: a feasible method with promising efficacy. Am J Clin Oncol. 2013;36:1–6.
- Angeli SI, Abi-Hachem RN, Vivero RJ, et al. L-N-acetylcysteine treatment is associated with improved hearing outcome in sudden idiopathic sensorineural hearing loss. Acta Otolaryngol. 2012;132:369–376.
- Eastwood H, Pinder D, James D, et al. Permanent and transient effects of locally delivered n-acetyl cysteine in a guinea pig model of cochlear implantation. Hear Res. 2010;259:24–30.
- Wu YJ, Muldoon LL, Neuwelt EA. The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway. J Pharmacol Exp Ther. 2005;312:424–431.
- Cu A, Ye Q, Sarria R, et al. N-acetylcysteine inhibits TNF-alpha, sTNFR, and TGF-beta1 release by alveolar macrophages in idiopathic pulmonary fibrosis in vitro. Sarcoidosis Vasc Diffuse Lung Dis. 2009;26:147–154.